: Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT / Polverelli, N.; Bonneville, E. F.; de Wreede, L. C.; Koster, L.; Kroger, N. M.; Schroeder, T.; Peffault de Latour, R.; Passweg, J.; Sockel, K.; Broers, A. E. C.; Clark, A.; Dreger, P.; Blaise, D.; Yakoub-Agha, I.; Petersen, S. L.; Finke, J.; Chevallier, P.; Helbig, G.; Rabitsch, W.; Sammassimo, S.; Arcaini, L.; Russo, D.; Drozd-Sokolowska, J.; Raj, K.; Robin, M.; Battipaglia, G.; Czerw, T.; Hernandez-Boluda, J. C.; Mclornan, D. P.. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 99:5(2024), pp. 993-996. [10.1002/ajh.27262]
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT
Battipaglia G.;
2024
Abstract
: Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.| File | Dimensione | Formato | |
|---|---|---|---|
|
2024 - Polverelli - Impact of comorbidities and body mass index on the outcomes of allogeneic - American J Hematol.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
